Inactive Instrument

MediRatt AB Stock Swiss Exchange

Equities

MEDR.B

SE0003656834

Advanced Medical Equipment & Technology

End-of-day quote Swiss Exchange
- SEK - Intraday chart for MediRatt AB
Sales 2022 729K 68.97K Sales 2023 1.82M 172K Capitalization 72.17M 6.83M
Net income 2022 -23M -2.18M Net income 2023 -32M -3.03M EV / Sales 2022 36.3 x
Net Debt 2022 2.3M 217K Net cash position 2023 3.31M 313K EV / Sales 2023 37.8 x
P/E ratio 2022
-0.99 x
P/E ratio 2023
-2.07 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 13.76%
More Fundamentals * Assessed data
IZafe Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
IZafe Group AB Announces Ida Almgren to Step Down as CFO , Effective June 18, 2024 CI
IZafe Group AB Initiates a Strategic Move of its Production to Central Europe in Order to Be Able to Scale Up CI
IZafe Group AB Launches Dosell Version 3.0 CI
IZafe Group AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
IZafe Group AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
IZafe Group AB Receives Confirmed Order for 1,000 Dosell Units to the Netherlands CI
Helsingborg Municipality Cancels Procurement - Izafe Group Ready for New Opportunity in January CI
IZafe Group AB Won Procurement for Pharmaceutical Robots Potentially Worth SEK 5.5-13.8 Million CI
IZafe Group AB and Atea Sweden Enter into Agreement with VGR in the Field of Welfare Technology CI
IZafe Group AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
IZafe Group AB Announces the Appointment of Nomination Committee CI
IZafe Group AB in Partnership with Atea Sverige AB Wins Procurement Potentially Worth SEK 42 Million-SEK 52 Million CI
IZafe Group AB Completes the Implementation of Dosell in Spain and Ships First 30 Units CI
IZafe Group AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
More news
Managers TitleAgeSince
Chief Executive Officer 39 18-12-31
Director of Finance/CFO - 20-11-08
Chief Tech/Sci/R&D Officer 33 20-12-31
Members of the board TitleAgeSince
Chairman 82 13-06-13
Director/Board Member 71 18-12-31
Director/Board Member 49 20-12-31
More insiders
iZafe Group AB, formerly MediRatt AB, is a Sweden-based company that conducts research, development and marketing of medical products for medication and drug management. Its offering includes Dosell, a patented drug dispenser under development that can be used when medicating patients at home via remote monitoring; and MediKoll, an app that provides patients information about side effects, reactions and allergies linked to different types of medication. The Company operates in the pharmaceutical industry, hospitals and care homes, and Pharmacies and private healthcare markets. It is active globally.
Calendar
More about the company